AirSculpt Technologies Inc AIRS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AirSculpt Technologies, Inc. - AIRS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AirSculpt Technologies, Inc. - AIRS
AIRS Investors Have Opportunity to Join AirSculpt Technologies, Inc. Fraud Investigation with SBS Law
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AirSculpt Technologies, Inc. - AIRS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AirSculpt Technologies, Inc. - AIRS
Plastic surgery is booming with boomers. Here's how to cash in on the antiaging craze.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AirSculpt Technologies, Inc. - AIRS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AirSculpt Technologies, Inc. - AIRS
Trading Information
- Previous Close Price
- $0.74
- Day Range
- $0.70–0.75
- 52-Week Range
- $0.52–5.79
- Bid/Ask
- $0.72 / $0.73
- Shares Outstanding
- 73.93M
- Market Cap
- $53.08M
- Volume/Avg
- 491,824 / 1M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.34
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Stock Style Box
- Small Value
- Total Number of Employees
- 363
- Website
- https://www.airsculpt.com
Valuation
Metric | AIRS |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.52 |
Price/Sales | 0.34 |
Price/Cash Flow | — |
Price/Earnings
AIRS
Financial Strength
Metric | AIRS |
|---|---|
Quick Ratio | 0.62 |
Current Ratio | 0.85 |
Interest Coverage | −1.40 |
Quick Ratio
AIRS
Profitability
Metric | AIRS |
|---|---|
Return on Assets (Normalized) | −3.92% |
Return on Equity (Normalized) | −7.71% |
Return on Invested Capital (Normalized) | −2.27% |
Return on Assets
AIRS
Medical Care Facilities Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| HCA Healthcare Inc HCA | LOCK|%dDF?n | LOCK|V?Hq | $105B | |||
| Fresenius SE & Co KGaA Registered Shares FSNUF | — | LOCK|h@Q? | $33B | |||
| Fresenius SE & Co KGaA ADR FSNUY | — | LOCK|$DG^< | $33B | |||
| Tenet Healthcare Corp THC | LOCK|z@gNWK | LOCK|<@mlx | $22B | |||
| Encompass Health Corp EHC | — | LOCK|qrP% | $14B | |||
| Fresenius Medical Care AG FMCQF | — | LOCK|$%#d | $11B | |||
| Fresenius Medical Care AG ADR FMS | LOCK|rw$^hc | LOCK|RvwSx | $11B | |||
| Universal Health Services Inc Class B UHS | LOCK|?j$Q<m | LOCK|?BJ>q | $11B | |||
| DaVita Inc DVA | LOCK|&tmw!& | LOCK|smn?n | $11B | |||
| Ensign Group Inc ENSG | — | LOCK|gt$#m | $11B |